Concepedia

HER2 Blockade in Metastatic Collecting Duct Carcinoma (CDC) of the Kidney: A Case Report

Miguel H. Bronchud, S. Castillo, Santiago Escriva de Romaní, Santiago Mourelo, Alejandra Fernández, Cecilia Baena, Jesús Murillo, Joan C. Julia, Jordi Esquius, Rubén Romero,

Onkologie · 2012 · 26 citations · 16 references

DOIFull text

Open access

Abstract

Double HER2 blockade is an effective therapy in disseminated CDC even in the presence of brain metastases.

References

16

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

José Baselga, Javier Cortés, Sung‐Bae Kim et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

José Baselga, Ian Bradbury, Holger Eidtmann et al. · The Lancet · 2012 · 1.3K citations · Full text

, , +5

Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer

Kimberly Blackwell, Harold J. Burstein, Anna Maria Storniolo et al. · Journal of Clinical Oncology · 2010 · 955 citations · Full text

Collecting duct carcinoma of the kidney.

Shuangjin Shi, Xuen Yu · PubMed · 1997 · 210 citations

Collecting duct carcinoma of kidney.

John R. Srigley, John N. Eble · PubMed · 1998 · 191 citations